Compare BIO-TECHNE Corp (TECH) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs 22nd Century Group Inc — how do they compare? BIO-TECHNE Corp trades at $72.12 (market cap $11.24B), while 22nd Century Group Inc trades at $4.4 (market cap $1.52M). The key difference: BIO-TECHNE Corp is far larger — about 7394.7× 22nd Century Group Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| TECH | XXII | |
|---|---|---|
Market Cap | $11.24B | $1.52M |
Sector | Health | Technology |
52-Week High | $72.29 | $801.00 |
52-Week Low | $43.31 | $3.72 |
Enterprise Value | $11.32B | -$6.71M |
Dividend Yield | 0.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
